Viewing Study NCT00165360

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:08 AM
Ignite Modification Date: 2025-12-27 @ 11:35 PM
Study NCT ID: NCT00165360
Status: COMPLETED
Last Update Posted: 2009-11-02
First Post: 2005-09-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Prolonged Daily Temozolomide for Low-Grade Glioma
Sponsor: Dana-Farber Cancer Institute
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Glioma View
None Astrocytoma View
None Oligodendroglioma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None low-grade glioma View
None astrocytoma View
None oligodendroglioma View
None oligoastrocytoma View
None temozolomide View
None mixed oligoastrocytoma View